A NOVEL MODEL FOR PREDICTION OF HUMAN DRUG CLEARANCE BY ALLOMETRIC SCALING
- 1 September 2005
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 33 (9) , 1297-1303
- https://doi.org/10.1124/dmd.105.004143
Abstract
Sixty-one sets of clearance (CL) values in animal species were allometrically scaled for predicting human clearance. Unbound fractions (fu) of drug in plasma in rats and humans were obtained from the literature. A model was developed to predict human CL: CL = 33.35 ml/min × (a/Rfu)0.770, where Rfu is the fu ratio between rats and humans and a is the coefficient obtained from allometric scaling. The new model was compared with simple allometric scaling and the “rule of exponents” (ROE). Results indicated that the new model provided better predictability for human values of CL than did ROE. It is especially significant that for the first time the proposed model improves the prediction of CL for drugs illustrating large vertical allometry.Keywords
This publication has 59 references indexed in Scilit:
- Pharmacokinetics of the M1-agonist talsaclidine in mouse, rat, rabbit and monkey, and extrapolation to manXenobiotica, 2000
- Disposition of the Selective α1A-Adrenoceptor Antagonist Tamsulosin in Humans: Comparison with Data from Interspecies ScalingJournal of Pharmaceutical Sciences, 1997
- Clinical Pharmacokinetics of Antiepileptic Drugs in Paediatric PatientsClinical Pharmacokinetics, 1995
- FelbamateDrugs, 1993
- Interspecies Metabolism and Pharmacokinetic Scaling of Theophylline DispositionDrug Metabolism Reviews, 1990
- Prediction of the pharmacokinetics of cefodizime and cefotetan in humans from pharmacokinetic parameters in animals.Journal of Pharmacobio-Dynamics, 1990
- Pharmacokinetics of Nilvadipine in Healthy VolunteersThe Journal of Clinical Pharmacology, 1987
- Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogsXenobiotica, 1987
- Prediction of the disposition ofβ-lactam antibiotics in humans from pharmacokinetic parameters in animalsJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1982